Laboratory Corp of America Holdings (LH)
201.37
-2.80
(-1.37%)
USD |
NYSE |
Apr 30, 16:00
201.28
-0.09
(-0.04%)
After-Hours: 20:00
Laboratory Corp of America Holdings Cash from Financing (Quarterly): -11.70M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -11.70M |
December 31, 2023 | -446.50M |
September 30, 2023 | -1.097B |
June 30, 2023 | 1.545B |
March 31, 2023 | -60.60M |
December 31, 2022 | -372.60M |
September 30, 2022 | -452.20M |
June 30, 2022 | -479.70M |
March 31, 2022 | -17.70M |
December 31, 2021 | -1.009B |
September 30, 2021 | -281.70M |
June 30, 2021 | -325.40M |
March 31, 2021 | -450.10M |
December 31, 2020 | -1.00M |
September 30, 2020 | -396.70M |
June 30, 2020 | -16.90M |
March 31, 2020 | -102.80M |
December 31, 2019 | -449.40M |
September 30, 2019 | -115.00M |
June 30, 2019 | 414.90M |
March 31, 2019 | -103.20M |
December 31, 2018 | -802.90M |
September 30, 2018 | -128.90M |
June 30, 2018 | -393.10M |
March 31, 2018 | -65.00M |
Date | Value |
---|---|
December 31, 2017 | -480.30M |
September 30, 2017 | 1.019B |
June 30, 2017 | 106.80M |
March 31, 2017 | -51.90M |
December 31, 2016 | -369.30M |
September 30, 2016 | 6.70M |
June 30, 2016 | -307.70M |
March 31, 2016 | -0.70M |
December 31, 2015 | -239.60M |
September 30, 2015 | -86.70M |
June 30, 2015 | -118.80M |
March 31, 2015 | 3.630B |
December 31, 2014 | -58.80M |
September 30, 2014 | -18.40M |
June 30, 2014 | -25.40M |
March 31, 2014 | -98.00M |
December 31, 2013 | 95.40M |
September 30, 2013 | -126.80M |
June 30, 2013 | -74.10M |
March 31, 2013 | -412.80M |
December 31, 2012 | -130.70M |
September 30, 2012 | 446.60M |
June 30, 2012 | -125.10M |
March 31, 2012 | -191.60M |
December 31, 2011 | -83.40M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.097B
Minimum
Sep 2023
1.545B
Maximum
Jun 2023
-206.30M
Average
-303.55M
Median
Cash from Financing (Quarterly) Benchmarks
Quest Diagnostics Inc | -153.00M |
Invitae Corp | -3.381M |
Exact Sciences Corp | 10.04M |
Delcath Systems Inc | 0.001M |
Progyny Inc | -5.025M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -29.80M |
Cash from Investing (Quarterly) | -393.10M |
Free Cash Flow | 667.50M |
Free Cash Flow Per Share (Quarterly) | -1.932 |
Free Cash Flow to Equity (Quarterly) | -198.20M |
Free Cash Flow to Firm (Quarterly) | -127.60M |
Free Cash Flow Yield | 3.83% |